Skip to Main Content

Paper Details

Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial.
J Am Coll Cardiol
159
2006
Author NameAffiliation
Michael P HudsonHenry Ford Heart and Vascular Institute
  • 1 - 1

Datasets